Successful Treatment of Abdominal Wall Advanced Endometriosis-Associated Clear Cell Carcinoma with AKT Pathway Inhibitor: Case Report

The emergence of endometriosis-associated clear cell carcinoma (CCC) within the abdominal wall is a notably rare phenomenon. This condition predominantly impacts females who have previously undergone surgical interventions, including hysterectomy or caesarean section (C-section), with the malignant...

Full description

Saved in:
Bibliographic Details
Main Authors: Ya-Ting Ko, Ching-Hsuan Wu, Cheng-Shyong Chang, De-Wei Lai, Ta-Chih Liu
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/60/12/1946
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The emergence of endometriosis-associated clear cell carcinoma (CCC) within the abdominal wall is a notably rare phenomenon. This condition predominantly impacts females who have previously undergone surgical interventions, including hysterectomy or caesarean section (C-section), with the malignant transformation of endometriosis within the post-surgical abdominal scar posited as a likely mechanism. Herein, we delineate a distinctive case of endometriosis-associated CCC emanating from the abdominal wall. The therapeutic approach for the patient encompassed surgical resection, complemented by a regimen of adjuvant chemotherapy, radiotherapy, immunotherapy, and targeted therapy. Despite these measures, the patient experienced disease progression, manifested by bilateral inguinal lymph node involvement and metastasis to the left femoral bone. Advanced molecular diagnostics, specifically next-generation sequencing (NGS) of the resected specimen, identified a targetable <i>PIK3CA E726K</i> mutation. Subsequent treatment with alpelisib and everolimus was initiated, culminating in a sustained complete response.
ISSN:1010-660X
1648-9144